{"hands_on_practices": [{"introduction": "The physiological response of a pancreatic beta-cell to elevated glucose culminates in an electrical event: membrane depolarization. This practice provides a quantitative foundation for understanding this critical step in stimulus-secretion coupling. By modeling the beta-cell membrane as a simple circuit, you will calculate how changes in the conductance of adenosine triphosphate (ATP)-sensitive potassium ($K_{\\text{ATP}}$) channels directly alter the resting membrane potential, providing the essential trigger for insulin release [@problem_id:2591353].", "problem": "Adenosine triphosphate-sensitive potassium channels ($K_{\\text{ATP}}$) in pancreatic beta-cells regulate the resting membrane potential by providing a potassium-selective conductance that depends on intracellular adenosine triphosphate (ATP). Consider a simplified passive membrane model in which the membrane is isopotential and contains only two parallel, ohmic conductances: a potassium-selective conductance representing $K_{\\text{ATP}}$ with conductance $g_{K}$ and Nernst equilibrium potential $E_{K}$, and a nonselective leak conductance with conductance $g_{L}$ and reversal potential $E_{L}$. Assume a quasi-steady state in which capacitive current is negligible and the total transmembrane current is zero. The ionic current through each pathway is given by Ohm’s law, $I_{i} = g_{i}\\,(V_{m} - E_{i})$, where $V_{m}$ is the membrane potential.\n\nYou are given initial values $g_{K} = 10\\ \\mathrm{nS}$ with $E_{K} = -80\\ \\mathrm{mV}$, and $g_{L} = 2\\ \\mathrm{nS}$ with $E_{L} = -50\\ \\mathrm{mV}$. To model the effect of glucose-stimulated closure of $K_{\\text{ATP}}$ channels by ATP, assume $g_{K}$ is halved to $g_{K}^{\\prime} = \\tfrac{1}{2}\\,g_{K}$ while $g_{L}$ and both reversal potentials remain unchanged.\n\nStarting only from current balance at steady state ($\\sum I_{i} = 0$) and the ohmic form of individual ionic currents, derive the steady-state expression for $V_{m}$ in terms of $\\{g_{K}, g_{L}, E_{K}, E_{L}\\}$ and compute $V_{m}$ before and after halving $g_{K}$. Provide both values as a row matrix in the order $\\bigl(V_{m,\\text{before}},\\,V_{m,\\text{after}}\\bigr)$, rounded to four significant figures. Express your answer in millivolts (mV).", "solution": "The problem presented is a standard, well-posed exercise in biophysical modeling and is scientifically sound. It will be solved as stated.\n\nThe fundamental principle governing the steady-state membrane potential, $V_m$, is the law of charge conservation, which dictates that the total transmembrane current must be zero. The problem statement specifies a quasi-steady state where capacitive current is negligible. Therefore, the sum of all ionic currents across the membrane must equal zero. The model includes two such currents: the potassium current, $I_K$, flowing through the adenosine triphosphate-sensitive potassium ($K_{\\text{ATP}}$) channels, and a nonselective leak current, $I_L$.\n\nThe condition of zero total current is expressed as:\n$$\n\\sum I_i = I_K + I_L = 0\n$$\n\nEach ionic current, $I_i$, is described by an ohmic relationship, which is a form of Ohm's law applied to ion channels:\n$$\nI_i = g_i (V_m - E_i)\n$$\nwhere $g_i$ is the conductance of the channel population and $E_i$ is the Nernst equilibrium potential (or reversal potential) for that ion or set of ions.\n\nApplying this form to the two specified conductances gives:\n$$\nI_K = g_K (V_m - E_K)\n$$\n$$\nI_L = g_L (V_m - E_L)\n$$\n\nSubstituting these expressions into the current balance equation yields:\n$$\ng_K (V_m - E_K) + g_L (V_m - E_L) = 0\n$$\n\nTo derive the steady-state expression for $V_m$, we must solve this linear equation for $V_m$. Expanding the terms gives:\n$$\ng_K V_m - g_K E_K + g_L V_m - g_L E_L = 0\n$$\n\nWe collect the terms containing $V_m$ on one side of the equation and the remaining terms on the other:\n$$\nV_m (g_K + g_L) = g_K E_K + g_L E_L\n$$\n\nIsolating $V_m$ provides the general expression for the steady-state membrane potential as a function of the component conductances and their respective reversal potentials:\n$$\nV_m = \\frac{g_K E_K + g_L E_L}{g_K + g_L}\n$$\nThis expression reveals that the membrane potential is a weighted average of the individual equilibrium potentials, where the conductances serve as the weighting factors.\n\nWe now compute the numerical value of $V_m$ under the initial conditions (before the change in $g_K$). The given values are:\n$g_K = 10\\ \\mathrm{nS}$\n$E_K = -80\\ \\mathrm{mV}$\n$g_L = 2\\ \\mathrm{nS}$\n$E_L = -50\\ \\mathrm{mV}$\n\nSubstituting these values into the derived formula for $V_m$:\n$$\nV_{m,\\text{before}} = \\frac{(10\\ \\mathrm{nS})(-80\\ \\mathrm{mV}) + (2\\ \\mathrm{nS})(-50\\ \\mathrm{mV})}{10\\ \\mathrm{nS} + 2\\ \\mathrm{nS}} = \\frac{-800 - 100}{12}\\ \\mathrm{mV} = \\frac{-900}{12}\\ \\mathrm{mV} = -75\\ \\mathrm{mV}\n$$\n\nNext, we model the effect of glucose metabolism, which leads to the closure of $K_{\\text{ATP}}$ channels. This is represented by a reduction in the potassium conductance, $g_K$. The new conductance, $g_K'$, is given as half of the initial value:\n$$\ng_K' = \\frac{1}{2} g_K = \\frac{1}{2} (10\\ \\mathrm{nS}) = 5\\ \\mathrm{nS}\n$$\nThe other parameters, $g_L$, $E_K$, and $E_L$, remain unchanged. We compute the new steady-state membrane potential, $V_{m,\\text{after}}$, using the same general formula with the updated value for $g_K$:\n$$\nV_{m,\\text{after}} = \\frac{g_K' E_K + g_L E_L}{g_K' + g_L} = \\frac{(5\\ \\mathrm{nS})(-80\\ \\mathrm{mV}) + (2\\ \\mathrm{nS})(-50\\ \\mathrm{mV})}{5\\ \\mathrm{nS} + 2\\ \\mathrm{nS}}\n$$\n$$\nV_{m,\\text{after}} = \\frac{-400 - 100}{7}\\ \\mathrm{mV} = \\frac{-500}{7}\\ \\mathrm{mV}\n$$\n\nTo provide a numerical answer as requested, we perform the division and round to four significant figures:\n$$\nV_{m,\\text{after}} \\approx -71.42857\\dots\\ \\mathrm{mV}\n$$\nRounding to four significant figures gives $-71.43\\ \\mathrm{mV}$. The initial value, $V_{m,\\text{before}} = -75\\ \\mathrm{mV}$, when expressed to four significant figures, is $-75.00\\ \\mathrm{mV}$. The closure of potassium channels, a depolarizing influence, correctly results in a membrane potential that is less negative.\n\nThe final answer requires a row matrix of the two computed values, $(V_{m,\\text{before}}, V_{m,\\text{after}})$, in millivolts and rounded to four significant figures.", "answer": "$$\\boxed{\\begin{pmatrix} -75.00 & -71.43 \\end{pmatrix}}$$", "id": "2591353"}, {"introduction": "Once a beta-cell depolarizes and calcium influx occurs, what are the precise mechanics of insulin release? This exercise challenges you to move beyond the electrical signal and into the molecular machinery of exocytosis, specifically the roles of Soluble N-ethylmaleimide-sensitive factor Attachment protein Receptor (SNARE) proteins in the characteristic biphasic pattern of secretion. You will perform a thought experiment, predicting the physiological consequence of a specific molecular disruption to deepen your understanding of how distinct granule pools are mobilized and released [@problem_id:2591350].", "problem": "You isolate intact mouse pancreatic islets and perform a dynamic perifusion experiment to quantify insulin secretion. After establishing basal secretion at $3$ mM glucose, you impose a step to $16$ mM glucose at time $t=0$ for $20$ minutes and collect effluent every $1$ minute. In untreated control islets, the response is biphasic: a rapid first-phase peak within approximately $0$–$5$ minutes followed by a sustained second-phase elevation from approximately $5$–$20$ minutes. You then preincubate a matched islet preparation for $24$ hours with botulinum neurotoxin serotype A (BoNT/A), which specifically cleaves synaptosomal-associated protein of $25$ kilodaltons (SNAP-$25$) but does not cleave synaptosomal-associated protein of $23$ kilodaltons (SNAP-$23$). Assume glucose metabolism, closure of adenosine triphosphate (ATP)-sensitive potassium channels, membrane depolarization, and voltage-gated calcium ion ($\\mathrm{Ca^{2+}}$) entry remain intact under both conditions. Based on fundamental principles of biphasic insulin secretion and soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)–mediated exocytosis, which of the following best predicts how BoNT/A treatment will differentially affect the first phase versus the second phase of glucose-stimulated insulin secretion in this perifusion?\n\nA. Near abolition of the early first-phase peak with partial preservation of a slowly rising second phase that is reduced in amplitude and delayed in onset relative to control.\n\nB. Minimal change in the first-phase peak but near abolition of the second phase due to failure to mobilize newcomer granules.\n\nC. Similar proportional suppression of both phases, yielding a uniformly scaled-down biphasic response without a shift in timing.\n\nD. Augmentation of the first-phase peak due to accumulation of docked granules during preincubation, with an unchanged second phase.", "solution": "The problem statement will first be subjected to a rigorous validation procedure.\n\n### Step 1: Extract Givens\nThe following information is provided in the problem statement:\n- **System**: Isolated intact mouse pancreatic islets.\n- **Experiment**: Dynamic perifusion to quantify insulin secretion.\n- **Basal Condition**: Islets maintained at $3$ mM glucose.\n- **Stimulus**: A step change to $16$ mM glucose at time $t=0$ for a duration of $20$ minutes.\n- **Data Collection**: Effluent collected at $1$-minute intervals.\n- **Control Response**: A biphasic insulin secretion profile consisting of:\n    1.  A rapid first-phase peak from approximately $t=0$ to $t=5$ minutes.\n    2.  A sustained second-phase elevation from approximately $t=5$ to $t=20$ minutes.\n- **Treatment Condition**: Preincubation of a matched islet preparation for $24$ hours with botulinum neurotoxin serotype A (BoNT/A).\n- **Mechanism of BoNT/A**: Specific cleavage of synaptosomal-associated protein of $25$ kilodaltons (SNAP-$25$).\n- **Specificity of BoNT/A**: BoNT/A does not cleave synaptosomal-associated protein of $23$ kilodaltons (SNAP-$23$).\n- **Assumed Intact Pathways**:\n    - Glucose metabolism.\n    - Closure of adenosine triphosphate (ATP)-sensitive potassium channels.\n    - Membrane depolarization.\n    - Voltage-gated calcium ion ($\\mathrm{Ca^{2+}}$) entry.\n- **Question**: To predict the differential effect of BoNT/A treatment on the first versus the second phase of glucose-stimulated insulin secretion (GSIS).\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated against the established criteria.\n\n- **Scientifically Grounded**: The problem is firmly rooted in established principles of pancreatic beta-cell physiology. Biphasic insulin secretion is a canonical phenomenon. The roles of SNARE proteins, including SNAP-$25$ and SNAP-$23$, in exocytosis are well-characterized. The specific mechanism of BoNT/A as a protease for SNAP-$25$ is a fundamental concept in neurobiology and cell biology. The experimental setup (islet perifusion) and glucose concentrations ($3$ mM and $16$ mM) are standard in the field. The provided assumptions are scientifically reasonable for isolating the effect on the exocytotic machinery. The problem is scientifically sound.\n- **Well-Posed**: The problem provides a clear initial state (basal), a well-defined perturbation (glucose step), a specific molecular intervention (BoNT/A treatment), and a set of explicit assumptions that constrain the system. This structure allows for a unique, logical deduction of the outcome based on the provided principles. It is not underspecified or overconstrained.\n- **Objective**: The problem is stated using precise, technical language devoid of subjective or ambiguous terminology. Terms such as \"biphasic,\" \"SNARE-mediated exocytosis,\" \"SNAP-$25$,\" and \"BoNT/A\" have clear, universally accepted definitions in the scientific literature.\n\nThe problem statement exhibits no flaws. It is a valid, well-posed, and scientifically grounded problem that tests understanding of the molecular mechanisms underlying a complex physiological process.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A solution will be derived.\n\n### Derivation of Solution\nThe problem requires an understanding of the molecular basis of biphasic insulin secretion and the specific roles of different SNARE protein isoforms.\n\n1.  **Biphasic Insulin Secretion and Granule Pools**: The biphasic nature of insulin release reflects the existence of functionally distinct pools of insulin granules within the beta-cell.\n    - The **first phase** represents the fusion of the \"Readily Releasable Pool\" (RRP) of granules. These granules are already docked at the plasma membrane and are biochemically \"primed\" for immediate fusion upon the influx of $\\mathrm{Ca^{2+}}$ that follows membrane depolarization. This pool is small, accounting for the rapid but transient nature of the first-phase peak.\n    - The **second phase** is sustained and represents the mobilization of a much larger \"Reserve Pool\" of granules from the cell interior to the plasma membrane, followed by their docking, priming, and fusion. This multi-step process is slower, resulting in a delayed onset and sustained elevation of secretion.\n\n2.  **SNARE Complex and Exocytosis**: The fusion of granules with the plasma membrane is orchestrated by the SNARE complex. In pancreatic beta-cells, this complex critically involves a vesicle SNARE (v-SNARE, primarily VAMP2) on the granule membrane and target SNAREs (t-SNAREs, primarily Syntaxin-1 and a SNAP isoform) on the plasma membrane. The assembly of these proteins into a tight four-helix bundle pulls the two membranes together, driving membrane fusion.\n\n3.  **Role of SNAP-$25$ vs. SNAP-$23$**: Pancreatic beta-cells express two key SNAP isoforms: SNAP-$25$ and SNAP-$23$.\n    - **SNAP-$25$** is the canonical t-SNARE partner for Syntaxin-1. It is essential for the high-speed, highly $\\mathrm{Ca^{2+}}$-sensitive fusion characteristic of neuroendocrine secretion. Its function is particularly critical for the final priming steps that confer release readiness to the RRP. Therefore, SNAP-$25$ is indispensable for a normal, rapid first phase of insulin secretion.\n    - **SNAP-$23$** is an alternative isoform. While it can substitute for SNAP-$25$ in forming a SNARE complex, the resulting complex is kinetically less efficient and less sensitive to $\\mathrm{Ca^{2+}}$. Fusion mediated by SNAP-$23$ is slower and less robust than that mediated by SNAP-$25$.\n\n4.  **Effect of BoNT/A**: The problem states that BoNT/A cleaves and inactivates SNAP-$25$ but leaves SNAP-$23$ intact. The assumptions confirm that the upstream signaling cascade (glucose metabolism to $\\mathrm{Ca^{2+}}$ influx) is unaffected. The entire defect is therefore localized to the final fusion step, specifically the loss of SNAP-$25$ function.\n\n5.  **Predicted Outcome**:\n    - **Effect on First Phase**: The first phase is entirely dependent on the rapid fusion of the RRP. This rapid fusion is critically dependent on fully functional SNAP-$25$. With SNAP-$25$ cleaved by BoNT/A, granules cannot be properly primed for rapid release. Consequently, the RRP is either not formed or cannot fuse efficiently. This will lead to a severe reduction or **near abolition of the first-phase peak**.\n    - **Effect on Second Phase**: The second phase involves the slower process of mobilizing reserve granules. In the absence of SNAP-$25$, the intact SNAP-$23$ can partially substitute and mediate fusion. However, because SNAP-$23$-mediated fusion is kinetically inferior (slower and less efficient), the resulting secretory response will be significantly altered. We expect a **slowly rising phase of secretion** that is **markedly reduced in amplitude** and likely **delayed in its onset** compared to the robust second phase in control islets. There will be a **partial preservation** of secretion, but it will be weak and sluggish.\n\nThis detailed analysis leads to a specific prediction: the sharp first-phase peak will be almost completely eliminated, while a much smaller, slowly developing second phase will persist.\n\n### Option-by-Option Analysis\n\n**A. Near abolition of the early first-phase peak with partial preservation of a slowly rising second phase that is reduced in amplitude and delayed in onset relative to control.**\nThis statement aligns perfectly with the derived prediction.\n- \"Near abolition of the early first-phase peak\": Correct. The first phase is critically dependent on SNAP-$25$.\n- \"partial preservation of a slowly rising second phase\": Correct. The less efficient SNAP-$23$ can mediate some fusion.\n- \"reduced in amplitude and delayed in onset\": Correct. This reflects the inferior kinetics of SNAP-$23$-mediated exocytosis.\nTherefore, this option is **Correct**.\n\n**B. Minimal change in the first-phase peak but near abolition of the second phase due to failure to mobilize newcomer granules.**\nThis statement is incorrect. The first phase is the most sensitive to the loss of the fast-acting SNARE machinery component SNAP-$25$, so a \"minimal change\" is not expected. The primary defect is in fusion, not mobilization, although inefficient fusion can create a bottleneck that appears as a mobilization defect. The predicted effects on the two phases are reversed from what is mechanistically expected.\nTherefore, this option is **Incorrect**.\n\n**C. Similar proportional suppression of both phases, yielding a uniformly scaled-down biphasic response without a shift in timing.**\nThis statement is incorrect. It fails to account for the differential kinetic requirements of the two phases and the existence of a backup, albeit less efficient, fusion pathway via SNAP-$23$. The first phase, being kinetically more demanding, will be disproportionately affected compared to the second phase. The slower kinetics of SNAP-$23$ would also introduce a temporal shift (delay), contrary to the \"without a shift in timing\" claim.\nTherefore, this option is **Incorrect**.\n\n**D. Augmentation of the first-phase peak due to accumulation of docked granules during preincubation, with an unchanged second phase.**\nThis statement is biologically nonsensical. Cleavage of SNAP-$25$, a protein essential for fusion, will inhibit, not augment, secretion. Granules may dock but cannot be properly primed for fusion, thus they are not \"releasable\" and cannot contribute to an augmented response. They are effectively trapped at a pre-fusion step. The claim of an \"unchanged second phase\" is also incorrect, as this phase also relies heavily on efficient SNARE-mediated fusion.\nTherefore, this option is **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2591350"}, {"introduction": "After its release from the pancreas, insulin travels through the circulation to exert its effects on target tissues like the liver, muscle, and adipose tissue. This final practice focuses on the very first step of insulin action: its binding to receptors on the cell surface. You will apply first principles of the law of mass action to calculate receptor occupancy in a scenario where ligand concentration is significantly depleted by binding, a situation that demands a more rigorous quantitative approach than simplified models allow [@problem_id:2591430].", "problem": "A pancreatic beta-cell secretes insulin into the portal circulation where it encounters its target cell membrane containing the insulin receptor, a receptor tyrosine kinase. Consider a single class of noncooperative binding sites for insulin on the receptor and assume rapid equilibration relative to downstream signaling. The equilibrium dissociation constant is $K_d = 1\\ \\mathrm{nM}$. A cell patch contains a total receptor concentration $R_T = 100\\ \\mathrm{nM}$ and is exposed to a total insulin concentration $I_T = 10\\ \\mathrm{nM}$. Using first principles of the law of mass action and conservation of mass, and without assuming that free insulin is equal to total insulin unless such an approximation is demonstrably justified by scale analysis, derive the appropriate expression for the fraction of receptors occupied, defined as $\\theta = \\frac{[RI]}{R_T}$, where $[RI]$ is the concentration of the receptor–insulin complex at equilibrium. Compute $\\theta$ for the given parameters. Round your answer to $4$ significant figures. Express the final result as a unitless decimal number.", "solution": "The problem posed is a standard exercise in quantitative biochemistry and is a valid application of fundamental chemical principles. Validation proceeds as follows.\n\nFirst, extraction of the provided information:\n- The system is a ligand-receptor binding interaction between insulin ($I$) and its receptor ($R$).\n- The binding is noncooperative, involving a single class of sites.\n- The system is at equilibrium.\n- Equilibrium dissociation constant: $K_d = 1\\ \\mathrm{nM}$.\n- Total receptor concentration: $R_T = 100\\ \\mathrm{nM}$.\n- Total insulin concentration: $I_T = 10\\ \\mathrm{nM}$.\n- The objective is to derive an expression for and compute the fractional occupancy, $\\theta$, defined as $\\theta = \\frac{[RI]}{R_T}$.\n\nSecond, validation of the problem statement:\n- The problem is scientifically grounded, employing the law of mass action and conservation principles, which are cornerstones of chemical kinetics and equilibrium theory.\n- It is well-posed, providing all necessary parameters ($K_d$, $R_T$, $I_T$) to determine the state of the system at equilibrium.\n- The language is objective and precise.\n- The parameters are physiologically plausible for such a system.\n- The explicit instruction to avoid the common simplification ($[I] \\approx I_T$) without justification indicates a well-structured problem designed to test a rigorous understanding, not rote application of a simplified formula.\n\nVerdict: The problem is valid. We will proceed with the derivation and solution based on first principles.\n\nThe binding of insulin ($I$) to its receptor ($R$) forms a receptor-insulin complex ($RI$). The reaction is represented by the equilibrium:\n$$R + I \\rightleftharpoons RI$$\nAccording to the law of mass action, the equilibrium dissociation constant, $K_d$, is defined by the ratio of concentrations of free reactants to the concentration of the product at equilibrium:\n$$K_d = \\frac{[R][I]}{[RI]}$$\nwhere $[R]$ is the concentration of free receptors, $[I]$ is the concentration of free insulin, and $[RI]$ is the concentration of the receptor-insulin complex.\n\nThe system must also obey the laws of mass conservation for the total amounts of receptor and insulin.\nThe total receptor concentration, $R_T$, is the sum of free and bound receptors:\n$$R_T = [R] + [RI]$$\nThe total insulin concentration, $I_T$, is the sum of free and bound insulin:\n$$I_T = [I] + [RI]$$\nFrom these conservation equations, we can express the concentrations of the free species in terms of the complex concentration, $[RI]$, and the total concentrations:\n$$[R] = R_T - [RI]$$\n$$[I] = I_T - [RI]$$\nSubstituting these expressions for $[R]$ and $[I]$ into the equilibrium equation gives:\n$$K_d = \\frac{(R_T - [RI])(I_T - [RI])}{[RI]}$$\nThis equation relates the unknown concentration of the complex, $[RI]$, to the known parameters of the system. To solve for $[RI]$, we rearrange this equation into a standard quadratic form, $a x^2 + b x + c = 0$, where the variable $x$ is $[RI]$.\n$$K_d [RI] = (R_T - [RI])(I_T - [RI])$$\n$$K_d [RI] = R_T I_T - R_T [RI] - I_T [RI] + [RI]^2$$\n$$0 = [RI]^2 - (R_T + I_T + K_d)[RI] + R_T I_T$$\nThis is a quadratic equation for $[RI]$. The solution is given by the quadratic formula:\n$$[RI] = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a}$$\nWith $a=1$, $b=-(R_T + I_T + K_d)$, and $c=R_T I_T$, the solution for $[RI]$ is:\n$$[RI] = \\frac{(R_T + I_T + K_d) \\pm \\sqrt{(R_T + I_T + K_d)^2 - 4 R_T I_T}}{2}$$\nWe must select the physically meaningful root. The concentration of the complex, $[RI]$, cannot exceed the total concentration of either the receptor, $R_T$, or the ligand, $I_T$. Let us examine the positive root. The numerator would be $(R_T + I_T + K_d) + \\sqrt{(R_T + I_T + K_d)^2 - 4 R_T I_T}$. Since the term $4 R_T I_T$ is positive, the square root term is strictly less than $(R_T + I_T + K_d)$. The sum will be less than $2(R_T + I_T + K_d)$. However, a simpler analysis shows that the sum $(R_T + I_T + K_d)$ itself is greater than both $R_T$ and $I_T$. The addition of any positive value from the square root term will yield a result for $[RI]$ that is larger than $\\frac{1}{2}(R_T + I_T + K_d)$. Given the parameters $R_T = 100\\ \\mathrm{nM}$ and $I_T = 10\\ \\mathrm{nM}$, this value would be greater than $\\frac{1}{2}(100+10+1) = 55.5\\ \\mathrm{nM}$, which exceeds the total insulin concentration of $10\\ \\mathrm{nM}$. Therefore, the positive root is physically invalid. The correct solution must be the negative root:\n$$[RI] = \\frac{(R_T + I_T + K_d) - \\sqrt{(R_T + I_T + K_d)^2 - 4 R_T I_T}}{2}$$\nThe problem correctly mandates avoiding the simplification $[I] \\approx I_T$. This assumption is valid only when the concentration of bound ligand is negligible compared to the total ligand concentration, i.e., $[RI] \\ll I_T$. This typically occurs when $R_T \\ll I_T$. In our case, $R_T = 100\\ \\mathrm{nM}$ is an order of magnitude larger than $I_T = 10\\ \\mathrm{nM}$. This is a \"ligand-depletion\" or \"tight-binding\" regime where a significant fraction of the total ligand will be bound. The approximation is therefore invalid, and the use of the full quadratic solution is required.\n\nNow, we compute the value of $[RI]$ using the given parameters: $R_T = 100\\ \\mathrm{nM}$, $I_T = 10\\ \\mathrm{nM}$, and $K_d = 1\\ \\mathrm{nM}$.\nThe sum of concentrations in the numerator is:\n$$R_T + I_T + K_d = 100 + 10 + 1 = 111\\ \\mathrm{nM}$$\nThe product term is:\n$$4 R_T I_T = 4 \\times 100 \\times 10 = 4000\\ (\\mathrm{nM})^2$$\nThe term under the square root is:\n$$(111)^2 - 4000 = 12321 - 4000 = 8321\\ (\\mathrm{nM})^2$$\nThe square root is:\n$$\\sqrt{8321} \\approx 91.219515\\ \\mathrm{nM}$$\nSubstituting these values back into the expression for $[RI]$:\n$$[RI] = \\frac{111 - 91.219515}{2} = \\frac{19.780485}{2} = 9.8902425\\ \\mathrm{nM}$$\nFinally, we compute the fraction of occupied receptors, $\\theta$:\n$$\\theta = \\frac{[RI]}{R_T} = \\frac{9.8902425\\ \\mathrm{nM}}{100\\ \\mathrm{nM}} = 0.098902425$$\nRounding the result to $4$ significant figures as instructed gives $\\theta = 0.09890$.", "answer": "$$\\boxed{0.09890}$$", "id": "2591430"}]}